Cargando…

Population versus individual protection by pneumococcal conjugate vaccination

Detalles Bibliográficos
Autores principales:	Klugman, Keith P, Rodgers, Gail L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771528/ https://www.ncbi.nlm.nih.gov/pubmed/31000193 http://dx.doi.org/10.1016/S0140-6736(19)30039-X

Ejemplares similares

Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype–Specific Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Surveillance of the impact of pneumococcal conjugate vaccines in developing countries
por: Rodgers, Gail L, et al.
Publicado: (2015)

Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe
por: Rodgers, Gail L, et al.
Publicado: (2021)

Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean
por: Whitney, Cynthia G, et al.
Publicado: (2021)

Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV
por: Nunes, Marta C., et al.
Publicado: (2021)

Population Snapshot of Streptococcus pneumoniae Causing Invasive Disease in South Africa Prior to Introduction of Pneumococcal Conjugate Vaccines
por: Ndlangisa, Kedibone M., et al.
Publicado: (2014)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

COVID-19 pneumonia and the appropriate use of antibiotics
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

Impact of Pneumococcal Conjugate Vaccination of Infants on Pneumonia and Influenza Hospitalization and Mortality in All Age Groups in the United States
por: Simonsen, Lone, et al.
Publicado: (2011)

Population immunity and vaccine protection against infection
por: Leshem, Eyal, et al.
Publicado: (2021)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
por: Bhorat, As’ad E., et al.
Publicado: (2015)

HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV)
por: Meiring, Susan, et al.
Publicado: (2016)

Integrated pneumonia surveillance: pandemics and beyond
por: Ginsburg, Amy Sarah, et al.
Publicado: (2022)

Should UK Pneumococcal Vaccine Eligibility Criteria Include Alcohol Dependency in Areas with High Alcohol-Related Mortality?
por: Mooney, John D., et al.
Publicado: (2018)

Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa
por: von Mollendorf, Claire, et al.
Publicado: (2017)

Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States
por: McGarry, Lisa J, et al.
Publicado: (2013)

Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals
por: Nunes, Marta C., et al.
Publicado: (2012)

Pneumococcal Conjugate Vaccines and Otitis Media
por: Taylor, Sylvia, et al.
Publicado: (2012)

Serotype-specific Cardiac Involvement in Pneumococcal Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

PERCH in Perspective: What Can It Teach Us About Pneumonia Etiology in Children?
por: Klugman, Keith P., et al.
Publicado: (2017)

Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data
por: Strutton, David R, et al.
Publicado: (2012)

Strengths and weaknesses of pneumococcal conjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2023)

COVID-19 vaccination protects children and adolescents
por: Irving, Stephanie A, et al.
Publicado: (2023)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal Carriage
por: Roca, A., et al.
Publicado: (2012)

The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults
por: Feldman, Charles, et al.
Publicado: (2020)

Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae. Microorganisms 2022, 10, 560
por: Cossrow, Nicole, et al.
Publicado: (2022)

Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population
por: Collins, Deirdre A., et al.
Publicado: (2017)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study
por: Mackenzie, Grant A., et al.
Publicado: (2022)

Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine
por: Valente, Carina, et al.
Publicado: (2012)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
por: Hoffman, Thijs W., et al.
Publicado: (2020)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Using LASSO Regression to Estimate the Population-Level Impact of Pneumococcal Conjugate Vaccines
por: Wong, Anabelle, et al.
Publicado: (2023)

Economic evaluation of pneumococcal conjugate vaccination in The Gambia
por: Kim, Sun-Young, et al.
Publicado: (2010)

Conjugate Pneumococcal Vaccines: Need and Choice in India
por: Malik, Akash, et al.
Publicado: (2013)

Pneumococcal vaccination of older adults: Conjugate or polysaccharide?
por: Hollingsworth, Rosalind, et al.
Publicado: (2014)

Pneumococcal Conjugate Vaccine impact assessment in Bangladesh
por: Baqui, Abdullah H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_au8fct92bnqbok3obj54ntpmsc